Showing results (591-600 of 661) with videos related to
Sort By:
Pageof 67
Nature Cancer|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialElizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.Nature Cancer|June 10, 2021
An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemiaJeevisha Bajaj, Michael Hamilton, Yutaka Shima, et al.Nature Cancer|March 9, 2023
Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunityYuanzhong Wu, Liwen Zhou, Yezi Zou, et al.Nature Cancer|August 25, 2025
Characterization of cis-regulatory elements and functional variants in colorectal cancer using epigenomics and CRISPRi screeningsZequn Lu, Can Chen, Heng Zhang, et al.Nature Cancer|January 29, 2026
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trialKari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.Nature Cancer|January 9, 2026
Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trialGuangwen Yuan, Ge Lou, Jundong Li, et al.Nature Cancer|March 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancersLei Shi, William Shen, Mindy I Davis, et al.Nature Cancer|July 14, 2020
L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancerKaruna Ganesh, Harihar Basnet, Yasemin Kaygusuz, et al.Nature Cancer|April 28, 2022
Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competitionJiang Li, Yingying Ye, Zhihan Liu, et al.Nature Cancer|September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degradersXuewei Wu, Xiaobao Yang, Yan Xiong, et al.Pageof 67